EE Impact

EuBiologics

South Korea · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

Biotechnology company with Headquarter in South Korea. EuBiologics Co.,Ltd. is a company of CRMO (Contract Research and Manufacturing Organization), providing customized services for mammalian cell and microbial derived biopharmaceutical from cell line development to GMP production.

Status last verified 03/08/2026Source checked 22/09/2023Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 22/09/2023 · Reference ↗

EuBiologics signed another technology transfer agreement and contract to supply raw materials for its meningococcal quadrivalent vaccine to Nanolek, a Russian biopharmaceutical.

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.